Straumann Holding AG

The Straumann Group will acquire a 34% stake in Warantec, a Yuhan Corp. subsidiary specializing in dental implants, and receive exclusive distribution rights outside South Korea.

Straumann will acquire the remaining 70% of French dental implant maker Anthogyr, taking its stake from 30% to 100%. The deal is expected to close in early Q2 2019; financial terms were not disclosed.

The Straumann Group has signed an agreement to increase its stake in Anthogyr from 30% to full ownership. The transaction is expected to close early in the second quarter of 2019. Financial details were not disclosed.

Straumann Holding AG will purchase shares from existing shareholders of T-Plus, a Taiwanese manufacturer of implant systems, increasing its ownership from 49% to up to 60%. The consolidation is expected in Q4 2018.

The Straumann Group acquired a 30% stake in its biomaterials partner botiss medical AG for an undisclosed sum, to expand distribution of botiss products and secure access to its technology.

Straumann Holding AG announced it will buy a 70% stake in Batıgrup Dental Products, an Ankara-based company and its sole authorized distributor in Turkey. The deal also includes assets of Batı Dental and Botiss Dental.

Straumann Group acquired ClearCorrect, a manufacturer of clear aligners, for approximately $150 million. ClearCorrect will continue operations in Round Rock, Texas.

Rodo Medical and Straumann Group announced that Straumann increased its stake in Rodo Medical from 12% to 30% and obtained exclusive distribution rights for Rodo's Smileloc dental implant retention devices outside North America and South Korea, with an option to increase to 51% in 2021.

Straumann Holding AG announced its decision to acquire an additional 49% stake to become the 100% owner of Medentika GmbH, a medical device company.